HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis, characterization, molecular docking and cytotoxic activity of novel plumbagin hydrazones against breast cancer cells.

Abstract
Novel plumbagin hydrazonates were prepared, structurally characterized and evaluated for anti-proliferative activity against estrogen receptor-positive MCF-7 and triple negative MDA-MB-231 and MDA-MB-468 breast cancer cell lines which exhibited superior inhibitory activity than parent plumbagin compound. Molecular docking studies indicated that hydroxyl groups on plumbagin and hydrazonate side chain favor additional hydrogen bonding interactions with amino acid residues in p50-subunit of NF-κB protein and these compounds inhibited NF-κB expression which may be responsible for the enhanced anti-proliferative activity. These compounds were found to be more effective against triple negative breast cancer cells and might serve as a starting point for building future strategies against triple negative breast cancers which are known for their increased drug resistance and poor prognosis of breast cancer patients.
AuthorsPrasad Dandawate, Ejazuddin Khan, Subhash Padhye, Himanshi Gaba, Swati Sinha, Jyoti Deshpande, K Venkateswara Swamy, Madhukar Khetmalas, Aamir Ahmad, Fazlul H Sarkar
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 22 Issue 9 Pg. 3104-8 (May 01 2012) ISSN: 1464-3405 [Electronic] England
PMID22483392 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Ltd. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Antineoplastic Agents, Phytogenic
  • Hydrazones
  • NF-kappa B
  • Naphthoquinones
  • plumbagin
Topics
  • Antineoplastic Agents (chemical synthesis, pharmacology)
  • Antineoplastic Agents, Phytogenic
  • Binding Sites
  • Breast Neoplasms (drug therapy, pathology)
  • Cell Line, Tumor
  • Female
  • Humans
  • Hydrazones (chemistry, pharmacology)
  • Hydrogen Bonding
  • NF-kappa B (metabolism)
  • Naphthoquinones (chemistry)
  • Protein Binding
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: